methods. In contrast, analysis of cerebrospinal fluid (CSF) provides important information about the inflammatory response that occurs in NC, permitting a better understanding of the interaction between the parasite and host. The classification of NC lesions into active or inactive based only on imaging criteria seems increasingly more inadequate since inactive forms detected by imaging exams might present important clinical and CSF 2 . Recent studies have tried to identify markers able to detect brain damage in diseases such as NC 9 . However, the efficacy of these markers seems to be related to clinically and laboratory confirmed overtly active disease, with inflammatory activity being detected in most cases. A lower sensitivity of some markers to certain types of brain lesions has also been demonstrated 10 . A series of biochemical and morphological events lead to cell death, a sequence generically called programmed cell death (PCD). In contrast to necrotic cell death, PCD is an active process in which cells are dying and are removed safely without causing inflammation.
Among the markers of neuronal death, Fas protein has been widely studied. Fas belongs to the tumor necrosis factor (TNF) receptor superfamily and is the main proapoptotic protein 11 . Interaction of the soluble form of Fas protein with its receptor (FasL) leads to the formation of a cell death-inducing signaling complex that activates different types of caspases, causing mitochondrial damage and, finally, proteolytic death 12 .
The apoptotic process involves the participation of affected cells in the cascade of self-destruction that culminates in the degradation of DNA through the activation of endonucleases, cell disintegration and the formation of "apoptotic bodies" 13 . Since NC can result in cell death, it would be of clinical importance to determine the type of cell death that occurs during the different cystic phases of the disease and whether the presence of seizures interferes with the pattern of death observed. Therefore, the objective of the present study was to quantify soluble Fas protein in CSF of patients with active and calcified NC with or without epileptic seizures.
METHODS

Patients
All patients included in the study were selected prospectively among patients submitted to CSF puncture as requested by the physician. Patients with NC were diagnosed based on a combination of imaging findings [cranial computed tomography (CT) and brain magnetic resonance (MR) imaging], CSF alterations, including an immunoenzymatic reaction to NC, epidemiological criteria and clinical findings according to the criteria of Del Brutto et al. 4 . Using the classification suggested by Carpio et All patients with seizures who presented signs of hydrocephalus and fever, and whose last seizure episode occurred within a period of less than 4 days and more than 60 days were excluded from the study.
Patients included in the study who belonged to the group with inactive or calcified cysts were submitted to CSF puncture for the investigation of possible reinfestation with cysticerci associated with symptoms, such as limb paresthesia, dizziness, vertigo and tinnitus. These symptoms were diagnosed after clinical investigation to be part of osteoarticular diseases of the spine and vestibular system disorders. CSF puncture was performed within a period of 4 to 30 days after the last seizure episode in patients of the groups with epileptic seizures.
All subjects were subjected to CT scan or brain MR. All subjects were submitted to lumbar puncture and CSF cytomorphological examination.
The project was approved by the Ethics Committee of Universidade Federal de São Paulo (UNIFESP, process 0857/05).
Collection of cerebrospinal fluid samples CSF samples were collected by the responsible physician after the patient had signed a free informed consent form according to the guidelines of the Scientific Department of the Brazilian Academy of Neurology and UNIFESP. With the patient in the sitting position, lumbar puncture was performed in the L4/L5 intervertebral space using disposable Quincke needles (23 G x 90 mm or 22 G x 90 mm) with a short bevel. Samples containing red blood cells due to traumatic lumbar puncture were discarded. For the control group, CSF samples were collected at the time of lumbar puncture for the surgical procedure before injection of the anesthetic. Samples from patients with a diagnosis of NC were transported on ice, divided into aliquots and frozen at -70ºC until the time for processing at the laboratory of the Discipline of Experimental Neurology, UNIFESP.
Determination of Fas protein concentration by ELISA
The concentration of soluble Fas in CSF of the patients was measured by ELISA using the Quantikine kit (R&D Systems) according to manufacturer instructions. Briefly, 100 µL of the CSF sample or different concentrations of recombinant human soluble Fas provided for construction of the standard curve (62.5, 125, 250, 500, 1000, 2000 pg/mL) were diluted in reaction buffer and incubated in duplicate for two hours at room temperature. The wells were washed three times with phosphate-buffered saline, and the biotinylated secondary antibody against human soluble Fas (50 ng/mL) was added. The plates were incubated for two hours at room temperature. After repeated washes ( four times), the samples were incubated with HRP-conjugated streptavidin for 30 minutes. Bound antigen was detected by incubation with tetramethylbenzidine for 30 minutes. The reaction was stopped by the addition of 2 N sulfuric acid as blocking buffer. Optical densities were read at 450 nm over the first 30 minutes, with correction at 540 and 570 nm.
Statistical analysis
Fas concentrations were analyzed by the t-test for independent samples. ANOVA or the F test was used to compare all groups as a whole. If a significant difference was detected (p<0.05), multiple comparisons were performed to determine between which groups the difference occurred.
RESULTS
Fifty patients (27 men and 23 women) ranging in age from 19 to 59 years were studied. The mean age was 38.8 years (standard deviation 8.5).
The samples were classified into active cysts, calcified cysts and controls, and the groups were then subdivided into patients with and without seizures. All patients were submitted to cranial CT or MR in order to be included in the study. The CT or MR images and CSF analysis, consisting of cytomorphological examination, protein quantification, electrophoresis, glucose and chloride measurement, revealed no signs of an inflammatory reaction in any of the patients. All patients of the group with active cysts presented multiple intraparenchymatous cysts, eight patients of the group with calcified cysts presented single intraparenchymatous calcification (three of the group with seizures and five of the group without seizures) and the remaining patients presented multiple calcified cysts. Images showing the presence of 6 to 100 cysts were defined as multiple cysts and classified as moderate infestation according to García et al. 15 . Among the four groups with NC studied, only the group of patients with calcified cysts without seizures presented CSF levels of Fas similar to those of the control group. Higher levels were observed in the other groups, but statistical analysis only revealed a significant difference when patients with calcified cysts and seizures were compared to the control group and to the group with calcified cysts without seizures, and when the latter was compared to the group with viable cysts without seizures. The percent increase in CSF levels of Fas was 36% (p=0.01), 55% (p=0.038) and 85% (p=0.011) in the groups of patients with active cysts without seizures, active cysts with seizures and calcified cysts with seizures, respectively, when compared individually to the control group.
In the group with calcified cysts, all patients were from rural areas, and no significant differences in CSF Fas levels were observed between patients with single and multiple intraparenchymatous calcification. The average normal reference value of Fas obtained for the control group by the immunoenzymatic method was 208.00 pg/mL. In contrast, an increase of Fas concentrations compared to the control group was observed in patients with viable and calcified cysts, except for the group of calcifications without seizures, as well as in patients of the same group with seizures compared to those without seizures (Table) . This finding suggests the occurrence of apoptotic activity accompanied by neuronal death in the two groups. However, a significant difference was only observed when the group of calcified cysts with seizures was compared to the control group and to the group of calcified cysts without seizures. 
DISCUSSION
Apoptosis participates in various vital physiological processes, such as embryo development, involution of the mammary gland after breast-feeding, control of tumor cell proliferation and regulation of immune cell populations. Mutations in genes that trigger the apoptotic process are the cause of different diseases 16, 17 . Since cell death is essential for life, it should follow a meticulous program. Any disturbance in this process, i.e., excessive or deficient death of cells, can cause a variety of diseases 18 . Excessive apoptosis may lead to neurodegenerative diseases (Alzheimer's and Parkinson's disease), secondary lesions after ischemia and osteoporosis, and can actively participate in parasitic diseases such as NC 19 . In the present study, the Fas levels observed in the two cystic forms of NC (active and calcified), except for calcified cysts without seizures, might be related to the activation of proapoptic cascades in neighboring neuronal cells as a reaction to these structures. The main clinical manifestations of NCC are epileptic seizures. These manifestations are directly associated with altered synaptic transmission, which results from changes in the concentrations of amino acid neurotransmitters in the CNS.
Numerous studies have measured Fas protein levels in blood of patients with different neoplastic, infectious, autoimmune and degenerative diseases, whereas studies discussing Fas measurement in CSF are scarce 20 . Elevated Fas levels are observed in patients in the advanced phase of diseases compared to those in the early stage. Mogi et al. 21 found elevated tissue and CSF concentrations of soluble Fas in nigrostriatal dopaminergic neurons of patients with Parkinson' s disease compared to the control group. Ciusani et al. 22 investigated soluble Fas levels in CSF of patients with multiple sclerosis compared to patients with other types of neurological diseases and healthy controls. The authors concluded that the participation of soluble Fas in the pathogenesis of multiple sclerosis suggests that a lower rate of apoptosis in CSF might be a characteristic of the disease, thus demonstrating the importance of Fas protein for the detection of neurological diseases, especially those related to dementia. In this respect, Zhou et al. 23 quantified soluble Fas levels in blood and CSF of patients with multiple sclerosis. Analysis of the two types of samples showed significantly elevated soluble Fas levels in patients in the active phase of disease compared to those in the inactive phase and to the control group. Martínez et al. 24 evaluated CSF concentrations of soluble Fas and interleukin 6 (IL-6) in ten patients with dementia of the Alzheimer type and ten control subjects, and detected a significant increase in soluble Fas and IL-6 concentrations in dementia patients compared to the control group and non-dementia patients. Felderhoff-Mueser et al. 25 observed high concentrations of soluble Fas in children with hydrocephalus, whereas the control group presented levels below the detection limit. Towfighi et al. 26 concluded that soluble Fas concentration is elevated in CSF of patients with HIV who present symptoms of dementia and it is correlated with the severity of the condition.
In the study of Owen-Schaub et al. 27 , elevated blood levels of soluble Fas in patients with melanoma were correlated with a poor prognosis and lower survival. This marker was found to be useful for the evaluation of disease progression and for the establishment of therapeutic strategies. In most studies, blood levels of Fas are compared between patients with diseases and control groups or patients without disease with normal reference values, being defined in different protocols such as that of the R&D Systems kit used in this study. However, normal reference values of Fas in CSF need to be established for patients without disease. CSF levels of Fas are generally compared between the early and advanced stages of the same disease.
In view of the results obtained, discussion of the term "inactive cyst" proposed by Sotelo et al. 28 and Carpio et al. 14 , with modifications, is necessary. We often observe that patients with calcified NC, or even physicians and healthcare professionals who are not familiar with the disease, falsely assume that the disease is resolved, harmless or cured, and will not result in further damage when analyzing the reports or results of imaging exams (CT and MR) containing the expression "inactive cyst". Although referring to the state of the parasite, modification of this classification is of the utmost importance since brain tissue containing calcified cysts 29 . We therefore propose replacement of the term "inactive cyst" with "reactive inactive cyst" to indicate the presence of a substance resulting from the death of a cysticercus that provokes a reaction.
The present results led us to conclude that an increase in CSF levels of Fas in patients with calcified and viable cysts presenting seizures and in patients with viable cysts without seizures indicates the presence of apoptosis in the brain parenchyma. For patients with calcified cysts, no significant differences in CSF Fas levels were observed between those presenting single and multiple intraparenchymatous calcification. One conclusion that can be drawn is that the presence of elevated CSF levels of Fas reflects the occurrence of neuronal injury and death due to active apoptosis.
Further studies are necessary to better understand the signaling pathways involved in apoptosis whose participants are proteins encoded by specific genes involved in the process of apoptosis. In this respect, the morphological and biochemical aspects of cell death due to apoptosis in different diseases, including NC, need to be better investigated.
Despite the absence of inflammatory signs in the imaging exams and CSF of patients with NC, a dynamic metabolic and inflammatory reaction might occur in the brain parenchyma. The present results emphasize the importance of considering NC as a progressive and active disease, even when the cysts are in the calcified phase. Replacement of the term "inactive cyst" with "reactive inactive cyst" is suggested.
